Skip to main content

Peer Review reports

From: ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

Original Submission
2 Nov 2017 Submitted Original manuscript
21 Nov 2017 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 2
21 Nov 2017 Submitted Manuscript version 2
4 Jan 2018 Reviewed Reviewer Report - Khawla Al-Kuraya
6 Feb 2018 Reviewed Reviewer Report - Sung Gwe Ahn
8 Mar 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 3
8 Mar 2018 Submitted Manuscript version 3
25 Mar 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 4
25 Mar 2018 Submitted Manuscript version 4
22 Apr 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 5
22 Apr 2018 Submitted Manuscript version 5
26 Apr 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 6
26 Apr 2018 Submitted Manuscript version 6
27 Apr 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 7
27 Apr 2018 Submitted Manuscript version 7
11 May 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 8
11 May 2018 Submitted Manuscript version 8
15 May 2018 Author responded Author comments - Yu-Lin Wang
Resubmission - Version 9
15 May 2018 Submitted Manuscript version 9
Publishing
18 May 2018 Editorially accepted
29 May 2018 Article published 10.1186/s12885-018-4517-0

You can find further information about peer review here.

Back to article page